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Abstract
Despite improvements in its treatment, HIV infection continues to affect Blacks disproportionally. 
Using National HIV Surveillance System data from 50 U.S. states and the District of Columbia, 
we examined demographic and epidemiologic differences between U.S.-born and non-U.S.-born 
Black adults. Of 110,452 Black adults reported with diagnosed HIV during 2008–2014 with 
complete country of birth information, 11.1% were non-U.S.-born. Non-U.S.-born were more 
likely to be older, female, have HIV infection attributed to heterosexual contact, have been 
diagnosed late, and live in the northeastern U.S. region. During 2014, the HIV diagnosis rate 
among African-born Black females was 1.4 times the rate of U.S.-born Black males, 2 times the 
rate of African-born Black males, and 5.3 times the rate of U.S.-born Black females. We elucidate 
the differences between U.S.-born and non-U.S.-born Blacks on which to base culturally 
appropriate HIV-prevention programs and policies.
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Introduction
HIV continues to disproportionally affect Blacks, despite notable declines in annual HIV 
diagnoses among all races [1]. During 2014, Blacks aged ≥ 13 years accounted for 
approximately 44% of HIV diagnoses [2], although only 14% of the total U.S. population 
Correspondence to: Hanna B. Demeke.
HHS Public Access
Author manuscript
J Immigr Minor Health. Author manuscript; available in PMC 2020 February 01.
Published in final edited form as:
J Immigr Minor Health. 2019 February ; 21(1): 30–38. doi:10.1007/s10903-018-0699-4.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
were Black [3]. Among Black adults and adolescents with HIV diagnosed in 33 states during 
2001–2007, 11.7% of them were non-U.S.-born [4]. Some states also reported a substantial 
proportion of their Black population with HIV were non-U.S.-born [5–9]. Non-U.S.-born 
Blacks with diagnosed HIV are more likely to be women, infected through heterosexual 
contact, and diagnosed at a late stage of disease [4–10]. As the Black population who were 
non-U.S.-born increases [11, 12], identifying differences between U.S.-born and non-U.S.-
born Blacks in HIV diagnosis rates and HIV-related risk behavior at the national level is 
crucial for public health practice.
This paper substantially expands on a previous study [4] that compared rates of HIV 
diagnoses among U.S.-born and non-U.S.-born Blacks using data from 33 states with name-
based reporting of HIV infection to the Centers for Disease Control and Prevention’s (CDC) 
National HIV Surveillance System (NHSS). Because data from all 50 states, the District of 
Columbia, and 6 U.S. dependent areas (American Samoa, Guam, Northern Mariana Islands, 
Puerto Rico, the Republic of Palau, and the U.S. Virgin Islands) are now available in NHSS, 
we are able to include data from all HIV reporting jurisdictions, substantially increasing the 
reliability and validity of the data. In 2013, 82% of Black immigrants lived in the Northeast, 
and the South [11], and 11 of the 17 newly added states and the District of Columbia (DC) 
are from those two regions. Also, 4 of the top 10 states (California, Maryland, 
Massachusetts, and Georgia) with the largest African-born population during 2008–2012 
[11] are among newly added states. With this additional data, we compared selected 
demographic characteristics, annual HIV diagnosis rates, late diagnosis of and survival after 
receiving an HIV diagnosis or an AIDS classification, between U.S.-born and non-U.S.-born 
Black adults, as well as between African- and Caribbean-born Black adults with 
considerably more precision [4].
Methods
We analyzed data reported to CDC for Black adults aged ≥ 18 years with HIV diagnosed 
during 2008–2014. CDC collects data through NHSS in collaboration with state and local 
partners. We categorized persons born in the United States and six dependencies as U.S.-
born and those born in other countries were classified as non-U.S.-born [13]. For geographic 
analysis, countries of birth were grouped by using the United Nations Demographic 
Yearbook [14]. The U.S. Census Bureau’s definitions of regions and classifications of urban 
and rural areas were used for our study [15, 16], and we classified cases according to the 
person’s area of U.S. residence at the time of HIV diagnosis. The four U.S. regions of 
residence used are defined by the Census Bureau as Northeast, Midwest, South, and West 
[16].
We examined distributions of HIV diagnoses by place of birth, selected demographics, and 
HIV-transmission risk factors. HIV diagnosis rates per 100,000 population were calculated 
by using the annual numbers of HIV cases as numerators and age, sex, race/ethnicity, and 
nativity data from the U.S Census Bureau’s American Community Survey 1-year estimates 
as denominators [17]. To examine temporal trends, we used linear regression to determine 
estimated annual percentage changes (EAPC) in HIV diagnosis rates by world region of 
birth and sex for 2008–2014.
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Finally, we used the standardized Kaplan–Meier method to estimate the probability of 
survival at 12, 24, and 36 months after a diagnosis of HIV infection and an AIDS 
classification. Survival analysis was limited to 52,270 Black adults with diagnosed HIV and 
22,137 Black adults with HIV infection classified as stage 3 (AIDS) during 2008–2010 with 
known vital status reported through December 31, 2013, to account for 3 years’ reporting 
delay.
Results
Demographic Characteristics
During 2008–2014, CDC received a total of 134,945 reports of Black adults having received 
a diagnosis of HIV infection from 50 states and the District of Columbia, of which 81.8% 
(110,452) had a complete country of birth information. Of 110,452 Black adults, 88.9% 
(98,156) were U.S.-born, and 11.1% (12,296) were non-U.S.-born (Table 1). The 
demographic characteristics of those with unknown place of birth are presented in Table 1. 
The proportion of people with diagnosed HIV infection with unknown place of birth 
increased from 15% in 2008 to 23% in 2014, while the proportion of diagnoses among non-
U.S.-born people maintained a uniform proportion ranging 8–10% (Data not shown). The 
world regions of birth for non-U.S.-born were Africa (52.8%), the Caribbean (41.6%), and 
others (5.3%). Among persons born in Africa, HIV diagnoses by country of birth varied, 
with Ethiopia (14.8%), Nigeria (12.9%), Kenya (8.0%), Cameroon (8.0%), and Liberia 
(6.3%) accounting for half of the diagnoses. The majority (63.0%) of persons born in the 
Caribbean were from Haiti, followed by Jamaica (24.4%), Trinidad and Tobago (5.1%), 
Bahamas (2.7%), Barbados (1.3%), and other Caribbean countries (3.6%) (Data not shown).
The majority (72.7%) of U.S.-born Black adults who received an HIV diagnosis were men, 
but more than half of non-U.S.-born group (52.8%) were women (Table 1). A higher 
percentage of African-born Black adults who received an HIV diagnosis (60.7%) were 
women compared with the percentage of women among U.S.-born (27.3%) and Caribbean-
born (44.7%) Black adults (Tables 1, 2). A higher percentage (27.3%) of U.S.-born Black 
adults with diagnosed HIV were aged 18–24 years, compared with 7.9% of non-U.S.-born 
Black adults (Table 1). Overall, a higher percentage (73.3%) of U.S.-born Black adults 
received an HIV diagnosis at age ≤ 44 years, compared with non-U.S.-born Black adults 
(64.2%) (Table 1). African-born Black adults had the highest percentages of persons aged 
25–34 years (30.4%) and aged 35–44 years (32.9%), compared with U.S.-born (26.8 and 
19.2%, respectively) and Caribbean-born (21.8 and 25.9%, respectively) Black adults 
(Tables 1, 2).
As shown in Table 1, HIV diagnoses attributed to heterosexual contact accounted for the 
highest percentage of HIV diagnoses for both U.S.-born and non-U.S.-born Black women. 
More than half (52.3%) of HIV diagnoses among non-U.S.-born Black men were attributed 
to heterosexual contact while 73.2% of HIV diagnoses among U.S.-born Black men were 
attributed to male-to-male sexual contact. The percentage of HIV diagnoses attributed to 
injection-drug use (IDU) was higher among U.S.-born Black adults, compared with non-
U.S.-born Black adults among both men and women (Table 1). The distribution of African- 
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and Caribbean-born Black adults who received an HIV diagnosis by transmission category 
was similar for both men and women (Table 2).
Most Black adults who received an HIV diagnosis during 2008–2014 lived in the South at 
the time of diagnosis, regardless of place of birth (Table 1). African-born persons were 
distributed more widely across the U.S. regions (29.3% in Northeast, 17.0% in Midwest, 
38.2% in South and 15.4% in West), whereas the majority of Caribbean-born persons 
resided in the Northeast (39.5%) and South (57.8%) (Table 2). Higher percentages of 
African-born Black adults with diagnosed HIV resided in the Midwest (17.0%) and West 
(15.4%) regions, compared with U.S.-born (12.4 and 7.5%, respectively) and Caribbean-
born (1.3 and 1.4%, respectively) Black adults. In contrast, a higher percentage of 
Caribbean-born Black adults resided in the Northeast (39.5%), compared with 16.5% of 
U.S.-born and 29.3% of African-born persons (Tables 1, 2).
Late-Stage Diagnosis of HIV Infection
Late-stage diagnosis of HIV infection refers to the receipt of an AIDS classification ≤ 3 
months after HIV diagnosis. Of 29,866 Black adults to whom country of birth information 
reported and received a late-stage diagnosis, 84.9% (25,367) were U.S.-born, and 15.1% 
(4499) were non-U.S.-born (Table 3). A higher percentage of non-U.S.-born Black adults 
had a late-stage diagnosis (36.6%) compared with 25.8% of U.S.-born Black adults (Tables 
1, 3). A slightly higher percentage of African-born (37.4%) than Caribbean-born Black 
adults (36.4%) received a late-stage diagnosis (Table 2). Table 3 presents demographic 
characteristics and transmission categories, by place of birth, for Blacks with an AIDS 
classification ≤ 3 months after an HIV diagnosis. Black adults, who received a late-stage 
diagnosis, were older among all Black adults. A higher percentage of female received a late-
stage diagnosis among U.S.-born and groups with unknown place of birth while a higher 
percentage of males received a late-stage diagnosis among non-U.S.-born Black adults. A 
higher percentage of Black females with diagnosed HIV attributed to IDU had late-stage 
diagnosis regardless of place of birth (Table 3).
Annual HIV Diagnosis Rates
Comparing annual rates of HIV diagnosis during 2008–2014 by sex and world region of 
birth, we found that African-born women had the highest rate, followed by U.S.-born men; 
U.S.-born women had the lowest rates for all years. During 2014, the highest annual HIV 
diagnosis rate was among African-born women (100.5/100,000 population) while the lowest 
rate was among U.S.-born women (19.1) (Table 4). The HIV diagnosis rate among African-
born women in 2014 was 1.4 times the rate of U.S.-born Black men, 2 times the rate of 
African-born men, and 5.3 times the rate of U.S.-born Black women.
Overall, a significant decline occurred (from 70.3 in 2008 to 44.7 in 2014) in the annual HIV 
diagnosis rate among Black adults (EAPC: −7.5; 95% CI −8.0 to −7.1; P < 0.0001); 
however, trends differed significantly by place of birth and sex (Table 4). The decrease 
among non-U.S.-born Black adults (EAPC: −6.1; 95% CI −7.8 to −4.3; P < 0.0001) was 
smaller than that observed among U.S.-born Black adults (EAPC: −7.7; 95% CI −8.1 to 
−7.4; P < 0.0001). During 2008–2014, U.S.-born Black women had the largest decline 
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(EAPC: −12.0; 95% CI −12.5 to −11.4; P < 0.0001), and non-U.S.-born women had the 
smallest (EAPC: −4.5; 95% CI −6.6 to −2.4; P< 0.0001) (Table 4). African-born women had 
the smallest decline in annual HIV diagnosis rates of all groups (EAPC: −5.0; 95% 
confidence interval [CI] −7.4 to −2.4; P= 0.0002), compared with U.S.-born men and 
Caribbean-born men and women (Table 4). We observed a declining trend among African-
born men and women from 2008 to 2011 followed by an upward trending line since 2011. 
The trend observed among Caribbean-born women was not as uniform as the trend observed 
among U.S.-born men, U.S.-born women and Caribbean-born men (Fig. 1).
Survival After an HIV Diagnosis and AIDS Classification
For Black adults living with diagnosed HIV in the United States during 2008–2010, we 
estimated that non-U.S.-born Black adults were more likely than U.S.-born Black adults to 
survive the first 3 years after diagnosis of HIV infection or an AIDS classification (Table 5). 
Survival 3 years after an HIV diagnosis or an AIDS classification was greater among non-
U.S.-born Black adults, compared with U.S.-born Black adults, regardless of sex. By sex, 
survival 3 years after an HIV diagnosis or an AIDS classification was greater among non-
U.S.-born Black (0.96 and 0.91, respectively), compared with U.S.-born women (0.92 and 
0.83, respectively) (Table 5).
Discussions
Our study found differences in diagnoses of HIV infection among Black adults in the United 
States by place of birth and sex. Unlike the previous study [4], our analysis included data 
from all 50 states and the District of Columbia. Thus, this study better highlights the Black 
populations at increased risk for HIV infection, the place of birth for those populations, 
which sex is most affected, and in what U.S. region the populations at greatest risk reside. 
The proportion of non-U.S.-born Blacks with diagnosed HIV infection remained consistent 
with the findings from the previous study [4]. Unlike the previous study [4], however, the 
majority of non-U.S.-born Black adults in our study were from Africa, which might be a 
reflection of increasing immigration from Africa. The number of African immigrants living 
in the United States increased by 135% during 2000–2013, compared with only a 33% 
increase in the number of Caribbean immigrants during that period [11]. In addition, data 
from some states with the largest African-born population during 2008–2012 (e.g., 
California, Maryland, Massachusetts, and Georgia [18]) were included in this analysis, 
compared with the three states that hosted > 75% of Caribbean immigrants (e.g., Florida, 
New York, and New Jersey [19]) that had been included in the previous study [4].
Although the South accounts for the largest percentage of Black adults with diagnosed HIV, 
which is consistent with the overall U.S. HIV infection distribution [20], African-born Black 
adults were distributed more widely across the four U.S. regions than U.S.- and Caribbean-
born cases. This finding was expected, given that approximately 95% of Black immigrants 
from the Caribbean were residents of the Northeast and South, compared with the more 
dispersed Black African immigrants, with 40% in the South, 25% in the Northeast, 19% in 
the Midwest, and 16% in the West in 2013 [11]. Understanding the difference in the 
distribution of non-U.S.-born cases is important for the development of culturally 
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appropriate and responsive HIV prevention and control measures and allocation of resources 
at the local level.
Compared with U.S.-born Black adults, non-U.S.-born Black adults were more likely to be 
female, receive their diagnosis at an older age, acquire HIV infection through heterosexual 
contact, and have infection classified as AIDS ≤ 3 months after initial HIV diagnosis. These 
findings are consistent with previous national [4, 21] and local level studies [5, 22]. Non-
U.S.-born Black adults had higher diagnosis rates than U.S.-born Black adults consistent 
with previous findings [4]. Our analysis, however, revealed disparities in HIV diagnosis 
among the different groups when analyzed by world region of birth. African-born women 
had the highest annual HIV diagnosis rate during 2008–2014, followed by U.S.- and 
African-born men.
Although earlier studies [4, 6, 21] highlighted the disproportionate HIV diagnosis rates 
among African-born women, our findings are the first to provide a national comparison 
between different groups within the U.S. Black population. This disparity mirrors the 
generalized epidemic reported from Sub-Saharan African and in the Caribbean. For 
example, East and Southern Africa is the home for 53% of all people living with HIV 
infection [23]. Limited HIV knowledge [4, 24, 25], cultural values and gender biases [25, 
26], delay in accessing HIV testing and health care [4, 6, 27], HIV-related stigma [28, 29] 
and possible HIV infection occurring at the country of origin before immigration to the 
United States [30] may contribute to disparities in HIV diagnoses among African-born 
women. It is essential to consider those factors when designing prevention programs for and 
providing HIV care to non-U.S.-born Blacks especially women.
A statistically significant decline occurred in the HIV diagnosis rate observed for Black 
adults during 2008–2014. These rate decreases, however, were not equivalent among groups 
when world region of birth and sex were considered. Our finding highlights differences 
between U.S.-born and non-U.S.-born Black adults, especially among women. HIV 
prevention and care strategies targeting U.S. Blacks might not be as applicable to non-U.S.-
born Blacks. Further research is also needed to evaluate whether the shift in the trend of HIV 
diagnosis rates observed in 2011, especially among African born Blacks, was the result of 
the 2010 change in the U.S. travel ban policy that allowed HIV-positive non-citizens to travel 
to and throughout the U.S and apply for a legal permanent residency.
Despite higher rates of HIV diagnosis observed among non-U.S.-born Black adults, a 
substantially higher percentage of non-U.S.-born Black adults survived ≥ 1 year after HIV 
infection or an AIDS classification compared with U.S.-born Black adults. This finding is 
consistent with existing evidence that Black immigrants have better life expectancies and 
health outcomes than their U.S.-born counterparts [31, 32]. One possible reason is that 
healthier and educated persons elect to immigrate and then maintain healthier lifestyles after 
relocation [32]. Another possible explanation is that factors putting non-U.S.-born Blacks at 
risk for HIV and access to HIV testing might not affect them the same way after they learn 
their HIV status; for example, non-U.S.-born Blacks might not recognize their risk and 
therefore might not access timely HIV care because of limited HIV knowledge [4, 24, 25], 
cultural values, gender biases [25, 26], or fear of HIV-related stigma [28, 29] as evidenced 
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by delays in accessing HIV testing and health care [4, 6, 27]. However, after non-U.S.-born 
Black adults receive HIV diagnosis and access HIV medical care, they are as likely as U.S.-
born Black adults to be engaged and to be retained in HIV-related medical care after 
diagnosis. A recent national study reported no substantial difference in the prevalence ratio 
of antiretroviral prescription and viral suppression between U.S-born and non-U.S.-born 
persons with an HIV diagnosis [8].
Our analyses are subject to certain limitations. First, these data only reflect cases of HIV 
infection reported to CDC and may not reflect all persons with HIV infection in the United 
States. Second, country of birth was not collected consistently across all jurisdictions and 
cases in persons with the unknown place of birth who received a diagnosis of HIV infection 
during 2008–2014 (24,493; 18%) were excluded from our analysis. The demographic 
characteristics of excluded cases are very similar to those of U.S.-born Blacks (see Table 1). 
Third, it is unknown whether a non-U.S.-born person was infected and on treatment before 
arrival to the U.S. Consequently, we were unable to assess whether differences in survival 
were due to differences in treatment. Although some treatment data are collected in NHSS, 
data are limited and not collected consistently across reporting jurisdictions.
This paper highlights disparities in HIV diagnosis rates within the U.S. Black population. 
Using a single race of African American or Black to represent all does not provide an 
accurate assessment of HIV infection among U.S. Blacks. Our findings demonstrate that 
identifying highly affected populations and providing accurate epidemiologic data are 
crucial for developing targeted and culturally appropriate HIV-prevention programs and 
policies. Additional analyses by world region or country of birth may provide information 
that can enhance the ability of public health officials, health care providers, and policy-
makers to develop interventions and policies that will aid in making progress in meeting 
national HIV prevention and care goals [33].
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Fig. 1. 
HIV diagnosis rates among U.S. Blacks, by sex and world region of birth, 2008–2014, 
United States. †HIV diagnosis rates per 100,000 population were calculated by using the 
annual numbers of HIV cases as numerators and the U.S. Census Bureau’s 2014 American 
Community Survey 1-year population estimates as denominators. The Census Bureau tool 
American FactFinder (https://factfinder.census.gov) provided the population denominators 
according to national origin and race/ethnicity
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Table 2
Diagnoses of HIV infection among African-born and Caribbean-born Blacks ≥ 18 years, by selected 
characteristics 2008–2014, United States
Characteristics African born Caribbean born
No. % No. %
Sex at birth
 Male 2548 39.3 2830 55.3
 Female 3942 60.7 2289 44.7
Age at diagnosis (year)
 18–24 446 6.9 429 8.4
 25–34 1971 30.4 1114 21.8
 35–44 2137 32.9 1328 25.9
 45–54 1222 18.8 1255 24.5
 55–64 567 8.7 710 13.9
 ≥ 65 147 2.3 283 5.5
Transmission category
Male
 Male-to-male sexual contact 992 40.0 1147 40.5
 Injection-drug use (IDU) 137 5.4 129 4.6
 Male-to-male sexual contact and IDU 42 1.6 25 0.9
 Heterosexual contacta 1369 53.7 1525 53.9
 Otherb 9 0.4 3 0.1
Female
 IDU 154 3.9 83 3.6
 Heterosexual contacta 3770 95.6 2201 96.1
 Otherb 17 0.4 6 0.3
U.S. region
 Northeast 1905 29.3 2021 39.5
 Midwest 1102 17.0 70 1.3
 South 2479 38.2 2955 57.8
 West 1004 15.4 73 1.4
Time to AIDS classification
 ≤ 3 months 2429 37.4 1861 36.4
 ≥ 4 months 4047 62.4 3256 63.6
 Not determinedc 14 0.2 2 0.0
 Total 6490 100.0 5119 100.0
a
Heterosexual contact with a person known to have or to be at high risk for HIV infection
b
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified
c
Month of HIV diagnosis or stage 3 classification is unknown
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Table 5
Survival for more than 12, 24, and 36 months after HIV diagnosis or AIDS classification among Blacks aged ≥ 
18 years, by sex and country of birth, 2008–2010, United States
Proportion survived (95% confidence interval)
After HIV infection diagnosis
No. > 12 months > 24 months > 36 months
U.S.-born
 Male 32,967 0.951 (0.948–0.953) 0.936 (0.933–0.938) 0.923 (0.920–0.926)
 Female 13,811 0.950 (0.946–0.954) 0.934 (0.930–0.938) 0.918 (0.914–0.923)
 Subtotal 46,778 0.951 (0.949–0.953) 0.935 (0.933–0.937) 0.922 (0.919–0.924)
Non-U.S. born
 Male 2666 0.950 (0.941–0.957) 0.937 (0.927–0.945) 0.927 (0.917–0.936)
 Female 2826 0.967 (0.960–0.973) 0.964 (0.956–0.970) 0.958 (0.950–0.965)
 Subtotal 5492 0.959 (0.953–0.964) 0.951 (0.945–0.956) 0.943 (0.937–0.949)
 Total 52,270 0.951 (0.950–0.953) 0.937 (0.935–0.939) 0.924 (0.922–0.926)
After Stage 3 (AIDS) classification
No. > 12 months > 24 months > 36 months
U.S.-born
 Male 13,934 0.894 (0.889–0.899) 0.869 (0.864–0.875) 0.849 (0.843–0.855)
 Female 5540 0.883 (0.874–0.891) 0.856 (0.846–0.865) 0.833 (0.823–0.843)
 Subtotal 19,474 0.891 (0.887–0.895) 0.866 (0.861–0.870) 0.845 (0.840–0.850)
Non-U.S born
 Male 1434 0.909 (0.893–0.923) 0.889 (0.871–0.904) 0.877 (0.859–0.893)
 Female 1229 0.922 (0.906–0.936) 0.915 (0.898–0.930) 0.908 (0.890–0.922)
 Subtotal 2663 0.915 (0.904–0.925) 0.901 (0.889–0.912) 0.891 (0.879–0.903)
 Total 22,137 0.894 (0.890–0.898) 0.870 (0.865–0.874) 0.851 (0.846–0.855)
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